TRIANA Biomedicines Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
50
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$120M
- Investors
-
12
TRIANA Biomedicines General Information
Description
Operator of a pharmaceutical company intended to discover and develop molecular glues. The company leverages technology to stabilize pre-existing or create de novo interactions between multiple proteins and alter the fate or functionality of the disease target, enabling healthcare professionals to develop products for a wide range of therapeutic applications.
Contact Information
Website
www.trianabio.comCorporate Office
- 1050 Waltham Street
- Suite 301
- Lexington, MA 02421
- United States
Corporate Office
- 1050 Waltham Street
- Suite 301
- Lexington, MA 02421
- United States
TRIANA Biomedicines Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series B) | 26-Nov-2025 | $120M | Completed | Generating Revenue | ||
| 3. Early Stage VC (Series A) | 20-Apr-2022 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 17-Sep-2021 | $10M | $16M | Completed | Startup | |
| 1. Seed Round | 06-Jul-2020 | $6M | $6M | Completed | Startup |
TRIANA Biomedicines Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A | ||||||||
| Seed-1 | 3,030,303 | $0.001000 | $3.3 | $3.3 | 1x | $3.3 | 3.57% | |
| Seed | 4,666,667 | $0.001000 | $3 | $3 | 1x | $3 | 5.5% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
TRIANA Biomedicines Comparisons
Industry
Financing
Details
TRIANA Biomedicines Competitors (2)
One of TRIANA Biomedicines’s 2 competitors is ADMA Biologics, a Formerly VC-backed company based in Ramsey, NJ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| ADMA Biologics | Formerly VC-backed | Ramsey, NJ | ||||
| XyloCor Therapeutics | Venture Capital-Backed | King of Prussia, PA |
TRIANA Biomedicines Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
TRIANA Biomedicines Patents
TRIANA Biomedicines Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026174042-A1 | Anaplastic lymphoma kinase (alk) degraders and uses thereof | Pending | 13-Feb-2025 | ||
| WO-2026151924-A1 | 2-(2, 6-dioxopiperidine-3-yl)-1, 3-dioxoisoindoline derivatives bearing an heteroaryl group as anaplastic lymphoma kinase (alk) degraders and uses thereof | Pending | 09-Jan-2025 | ||
| US-12565492-B2 | Anaplastic lymphoma kinase (alk) degraders and uses thereof | Active | 09-Aug-2024 | ||
| US-20260042752-A1 | Anaplastic lymphoma kinase (alk) degraders and uses thereof | Active | 09-Aug-2024 | ||
| WO-2026035974-A1 | Anaplastic lymphoma kinase (alk) degraders and uses thereof | Pending | 09-Aug-2024 | C07D413/14 |
TRIANA Biomedicines Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
TRIANA Biomedicines Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ascenta Capital | Venture Capital | Minority | ||
| Bessemer Venture Partners | Venture Capital | Minority | ||
| Finchley Healthcare Ventures | Venture Capital | Minority | ||
| Invus (Private Equity) | PE/Buyout | Minority | ||
| Regeneron Ventures | Corporate Venture Capital | Minority |
TRIANA Biomedicines FAQs
-
When was TRIANA Biomedicines founded?
TRIANA Biomedicines was founded in 2019.
-
Where is TRIANA Biomedicines headquartered?
TRIANA Biomedicines is headquartered in Lexington, MA.
-
What is the size of TRIANA Biomedicines?
TRIANA Biomedicines has 50 total employees.
-
What industry is TRIANA Biomedicines in?
TRIANA Biomedicines’s primary industry is Discovery Tools (Healthcare).
-
Is TRIANA Biomedicines a private or public company?
TRIANA Biomedicines is a Private company.
-
What is the current valuation of TRIANA Biomedicines?
The current valuation of TRIANA Biomedicines is .
-
What is TRIANA Biomedicines’s current revenue?
The current revenue for TRIANA Biomedicines is .
-
How much funding has TRIANA Biomedicines raised over time?
TRIANA Biomedicines has raised $246M.
-
Who are TRIANA Biomedicines’s investors?
Ascenta Capital, Bessemer Venture Partners, Finchley Healthcare Ventures, Invus (Private Equity), and Regeneron Ventures are 5 of 12 investors who have invested in TRIANA Biomedicines.
-
Who are TRIANA Biomedicines’s competitors?
ADMA Biologics and XyloCor Therapeutics are competitors of TRIANA Biomedicines.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
